Interferon redundancy counteracts proteolytic inactivation by SARS-CoV-2 3CL pro main protease

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Interferons (IFNs) are secreted during virus infection and induce antiviral responses through receptor-mediated phosphorylation of signal transducer and activator of transcription (STAT) proteins, leading to IFN-stimulated gene expression with antiviral activity. We previously reported that the SARS-CoV-2 main protease, 3CL pro , is secreted from infected cells through gasdermin D/E pores and retains proteolytic activity in human serum against extracellular substrates. Here, we show that 3CL pro selectively cleaves glycosylated IFN-λ1, IFN-λ2, and a rare naturally occurring variant of IFN-γ (Arg160Gln), but does not cleave wild-type IFN-γ, IFN-λ3, IFN-λ4, IFN-α proteins or IFN-β. We identified sites of O-linked glycosylation of IFN-λ1 at Thr 137 and one or more threonines or serine in the sequence 24 TSKPTTT 30 , and N-linked glycosylation at Asn 65 that were indispensable for signaling. Unexpectedly, O-glycosylation was also required for the cleavage and inactivation of IFN-λ1 by 3CL pro at two sites. Cleavage reduced STAT1 phosphorylation and impaired the induction of the IFN-stimulated proteins MX1, OAS2, and IFIT1. Although 3CL pro cleaved IFN-λ2 proximal to its N-terminus at ARLH 32 ↓GALP, cleavage neither disrupted signaling nor antiviral activity against SARS-CoV-2 and vesicular stomatitis virus. We further show that matrix metalloproteinases (MMPs) 2, 7, 8, and 12 degrade 3CL pro , whereas 3CL pro shows no activity against these MMPs.

IMPORTANCE

Extracellular cleavage of IFN-λ1 and IFN-λ2, and the selective inactivation of IFN-λ1 by 3CL pro , reveals a potential pathobiological role for secreted SARS-CoV-2 3CL pro . The redundancy of IFN signaling, together with differential cleavage susceptibilities of IFNs to 3CL pro and the degradation of 3CL pro by several secreted MMPs, provide host countermeasures that preserve antiviral defence in some settings. Our findings highlight the potential to discover additional extracellular 3CL pro substrates that may contribute to SARS-CoV-2 replication and COVID-19. The investigation of potential secretion, extracellular activity, and host substrates of proteases encoded by other virus families, including Picornaviridae, Flaviviridae, Adenoviridae, and Poxviridae, is also warranted. Finally, our findings support the development of cleavage-resistant IFN-λ1 as a potential broad-spectrum antiviral therapeutic.

Article activity feed